Dupont Nutrition Biosciences Aps

H. Lundbeck A/s

International N&h Denmark Aps

Jacob Flyvholm Cramer

Morten Krog Larsen

Igor Nikolaev

Thomas Eisele

Jayarama K Shetty

Piet Van Solingen

Sung Ho Lee

Shukun Yu

Sander Van Stigt Thans

Susan Arent Lund

Neville Marshall Fish

Peter Edvard Degn

Poul Nissen

Rikke Hoeegh Lorentsen

Jacob Lauwring Andersen

Lene Kragh

Paulien Kruithof

Tove Bladt

Suzy Breneman

Jeremy Labarge

Søren Skou Thirup

Morten Keller Grøftehauge

Esben Meldgaard Høgh Quistgaard

Peder Søndergaard Madsen

Jens Claus Munck Petersen

Karina Hansen Kjær

Wilhelmus Van Der Kleij

Zhen Ma

Lene Bojsen Jensen

Sang-Kyu Lee

Marc Anton Bernhard Kolkman

Anja Hemmingsen Kellett-Smith

Karina Hansen Kjer

Esben Meldgaard HØGH Quistgaard

Morten Keller GRØFTEHAUGE

Stepan Shipovskov

The present invention relates to polypeptides, specifically polypeptides having transgalactosylating activity and nucleic acids encoding these, and their uses in e.g. dairy product.

Polypeptides having transgalactosylating activity

The present disclosure provides methods, compositions, apparatuses and kits comprising two or more distant related glucoamylases in mashing having a synergistic effect on the released fermentable DPI sugar. Increased levels of DPI being primarily glucose is of high importance for high attenuation brewing applied for brewing low carb or light beers. In some embodiments, the present disclosure provides methods, apparatuses; compositions and kits for the use of two or more glucoamylases to increase the apparent specific activity in the mashing operation.

Production of brewer's wort having increase fermentable sugars for fermentation

Compositions and methods are provided comprising acetolactate decarboxylase (ALDC) enzyme variants having higher specific activity. Composition and method are provided where the ALDC variants are used in combination with metal ions to further increase stability and/or activity.

Acetolactate decarboxylase variants having improved specific activity

A host cell capable of expressing a polypeptide having &#x3b2;-galactosidase and/or transgalactosylating activity and which host cell is modified to be cellulase, mannanase and pectinase deficient.

Recombinant host cell expressing beta-galactosidase and/or transgalactosylating activity deficient in mannanase, cellulase and pectinase

The present invention describes a process for in situ generation of stable GOS in different dairy products by the use of a transgalactosylating &#x3b2;-galactosidase.

Method for preparing a dairy product having a stable content of galacto-oligosaccharide(s)

The present invention provides hemicellulytic enzyme variants. Specifically, the present invention provides xylanase variants having one or more modifications as compared to a parent xylanase enzyme resulting in at least one improved property. In addition, the present invention provides compositions comprising a xylanase variant of the invention. The present invention also provides methods of degrading hemicellulotic material, including arabino-xylan using compositions comprising a xylanase variant of the invention.

Composition and methods comprising a xylanase enzyme variant

The present invention relates to polypeptides having glucoamylase activity with improved properties and to compositions comprising these polypeptides suitable for use in the production of a food, beverage (e.g. beer), feed, or biofuel. Also described is an improved and cost-effective process for isolating glucoamylases suitable for large scale protein purification procedures. Furthermore, different methods and uses related to glucoamylases according to the invention are disclosed, such as in a brewing process.

Polypeptides having glucoamylase activity and method of producing the same

The present invention provides a Sortilin crystal and methods for growing said crystal. The invention furthermore provide methods for design of specific ligands based on the crystal structure of Sortilin. The present invention also relates to the preparation and use of such ligands for the preparation of a medicament for the treatment of disease, damage or disorders of the central and peripheral nervous systems.

Specific ligands to sortilin

Growing community of inventors

Højbjerg, Denmark

Jacob Flyvholm Cramer